Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat ...

Includes Detailed Profiles of Industry Giants Eli Lilly & Company, Pfizer, Sun Pharmaceutical Industries, Arcutis Biotherapeutics, Bristol-Myers Squibb, AbbVie, Regeneron Pharmaceuticals, and Aclaris ...

Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body.

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

Researchers at the Garvan Institute of Medical Research and UNSW Sydney have discovered why some people with celiac disease ...

These include now-common JAK inhibitors such as tofacitinib (Xeljanz ... Pregnant women should be included in clinical trials, for example, "especially if preclinical reproductive toxicity ...

Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to ...

Takeda is organized around five core businesses: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for over 80% of revenue. It also has a developing ...

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

Researchers at the Garvan Institute of Medical Research and UNSW Sydney have discovered why some people with coeliac disease continue to suffer ...

So taking them together can raise this risk even further. Examples of JAK inhibitor drugs: Here are some JAK inhibitors that may interact with Cosentyx: baricitinib (Olumiant) tofacitinib (Xeljanz ...

"For example, we found that many of these aberrant cells have mutations in the JAK-STAT pathway, which is already targeted by approved drugs known as JAK inhibitors. With more investigation ...